Bayer

AUDIO from Medialink, Bayer Healthcare and Onyx Pharmaceuticals: Facts About Hepatitis

NEW YORK, May 29 /PRNewswire/ -- How much do you know about hepatitis? Here's more on the importance of liver health and education. Listen to this report from Bayer Healthcare and Onyx Pharmaceuticals at: http://inr.mediaseed.tv/oneClip_C/?feed=Ybx9S3lY7r__59P8wyiGqelU6PdFR6h9 Reg...

Now Available: Bayer Diabetes Care's CONTOUR(R) Meters in Midnight Blue and Orange Burst

TARRYTOWN, N.Y., May 5 /PRNewswire/ -- Bayer Diabetes Care announced the introduction of two bold new colors to their line of CONTOUR(R) Color blood glucose meters -- Midnight Blue and Orange Burst -- that will provide people with diabetes more color options so their meter fits their own style. ...

J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards

FLORHAM PARK, N.J., April 23 /PRNewswire/ -- OTC Perspectives - a new division within the leading pharmaceutical conference and consulting company DTC Perspectives Inc. - has announced the finalists for the 2009 OTC National Advertising Awards. Among the leading healthcare brands named as finalist...

Nick Jonas and Bayer Diabetes Care Launch Creativity Contest to Encourage Kids With Diabetes to Express Their Simple Win

Three Grand Prize Winners Will Meet Nick Jonas TARRYTOWN, N.Y., April 13 /PRNewswire/ -- Bayer Diabetes Care and music sensation Nick Jonas of the Jonas Brothers invite kids and teens with diabetes to enter the Bayer "Express Your Simple Win Creativity Contest" online for a chance to meet Ni...

Podcast from Medialink, Bayer Healthcare LLC and WomenHeart: WomenHeart - Strong @Heart

NEW YORK, Feb. 3 /PRNewswire/ -- Though one in three women in this country has some form of heart disease, women are still not receiving the same in-hospital treatment that men do for heart attacks and as a result, may be more likely to die. (Please copy and paste the following link into you...

Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign

SEATTLE, Nov. 19 /PRNewswire/ -- A group of consumers filed a proposed nationwide class-action lawsuit earlier this week against Bayer Healthcare LLC, a subsidiary of Bayer AG (FRA: BAY), alleging the pharmaceutical giant skirted FDA requirements in marketing two aspirin-based drugs. (Logo...

Photos: Bayer Names New U.S. CEO

Greg Babe to Head Bayer Corporation Attila Molnar to Retire After 30 Years of Service PITTSBURGH, July 31 /PRNewswire/ -- The Management Board of Bayer AG announced today that Greg Babe will become President and CEO of Bayer Corporation and the Senior Bayer Represen...

Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives

- Barr Plans to Launch Generic Yasmin(R) on or before July 1, 2008 - Barr Plans to Launch Generic Yaz(R) on or before July 1, 2011 - Bayer to Continue Appeal of Yasmin(R) District Court Decision MONTVALE, N.J., June 24 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL )...

ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare

NGN Capital leads $12 Million in Series A First Tranche Financing SAN FRANCISCO and NEW YORK, May 7 /PRNewswire/ -- NGN Capital announced today the formation of ACT Biotech Inc., a new company dedicated to developing and commercializing targeted oral cancer drugs. ACT Biotech has entered in...

United Nations Environment Programme and Bayer Corporation Announce North American Winners of International Children's Painting Competition

First and Second Place Winners Hail from San Francisco Bay Area, Northern New Jersey WASHINGTON, April 22 /PRNewswire-USNewswire/ -- Cindy Liu, a fifth-grader at the Harker School in San Jose, Calif., and Connie Yu, a seventh-grader at John Adams Middle School in E...

More>>

Bayer in Medical Technology

FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A

Pivotal Data Show Prophylaxis Treatment with Kogenate FS Reduces the Risk of Joint Damage and Frequent Bleeds in Children with No Pre-Existing Joint Damage BERKELEY, Calif., Oct. 10 /PRNewswire/ -- Bayer HealthCare LLC announced today that the U.S. Food and Drug Administration (FDA) has appr...

Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data

SEATTLE, June 18 /PRNewswire-FirstCall/ -- On Wednesday, June 18, 2008, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific, members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq: CTIC ; MTA) management team will host a conference call to discuss agreement with Bayer Schering Pharm...

Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis

CAMBRIDGE, Mass., and BERLIN, Sept. 26 /PRNewswire-FirstCall/ -- Genzyme Corporation (Nasdaq: GENZ ) and Bayer Schering Pharma AG, Germany today announced that the first patient has been treated in the first of two planned Phase 3 trials examining the safety and efficacy of alemtuzumab for th...

Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN

Interim analysis of Phase 2 comparative study showed significant results in favor of alemtuzumab versus Rebif CAMBRIDGE, Mass. and WAYNE, N.J., May 02, 2007 /PRNewswire-FirstCall/ -- Genzyme Corporation and Bayer HealthCare Pharmaceutical today announced detailed interim results from the CAMMS223 ...

ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402

...ive and in substance patented antibody development platform. The scope and strength of this platform is also utilised by partners, such as ALK-Abello, bayer HealthCare, ImmunoGen, OrbusNeich, Sanofi-Aventis, UCB and XOMA. More information is available at http://www.bioinvent.com . (1) "The Surgeon ...

Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients

...t also has entered into an option, collaboration and license agreement with bayer Schering Pharma AG under which bayer Schering Pharma was granted an exclusive option to license a specified BiTE...

Micromet Presents Update on Blinatumomab's Response Rate and Duration in a Phase 1 Study in Non-Hodgkin's Lymphoma Patients

...t also has entered into an option, collaboration and license agreement with bayer Schering Pharma AG under which bayer Schering Pharma was granted an exclusive option to license a specified BiTE...

Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506

...3, 3560 ORLANDO, Fla., May 30 /PRNewswire/ -- bayer today announced results from Phase I and II trials... Medical Officer and Head of Global Development at bayer HealthCare. "We are encouraged by these Phase I a...igation in a broad spectrum of tumors. About bayer HealthCare Pharmaceuticals Inc. ...

Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting

... WAYNE, N.J., May 29 /PRNewswire/ -- bayer Healthcare Pharmaceuticals Inc. today announced th...us, MD, vice president, Medical Affairs, Oncology, bayer HealthCare Pharmaceuticals. Abstracts are now... information, visit www.leukine.com . About bayer HealthCare Pharmaceuticals Inc. ...

Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data

...nificant drug uptake in the treated vessel." bayer Schering Pharma AG (Berlin, Germany) is the owner ...technology and is developing it for market through bayer affiliate, MEDRAD, Inc. Kraig McEwen, senior vice...nia, in the United States. MEDRAD is a business of bayer Medical Care. More company information is availabl...

Bayer in Medical Products

RNA1c Control for Bayer DCA 2000 and 2000 + Analyzers

Description: RNA1c Control is an assayed quality control material used for monitoring the performance of Bayer DCA Analyzers that measure Hemoglobin A1c. It may be used on DCA 2000 and 2000+ analyzers....
Company:RNA Medical

CC 527 Blood Gas, Electrolyte, CO-Oximeter (Bayer® and AVOX Systems®) Control

Description:...yed quality control material used for monitoring the performance of blood gas, electrolyte, and CO-Oximeter instrumentation. It is for specific use on bayer analyzers that measure total hemoglobin and hemoglobin fractions (280, 288, and 270) and the AVOX Systems CO-Oximeters (4000 and 1000E). CC 527 may al...
Company:RNA Medical

CC 527 Blood Gas, Electrolyte, CO-Oximeter (Bayer and AVOX Systems) Control

Description:...yed quality control material used for monitoring the performance of blood gas, electrolyte, and CO-Oximeter instrumentation. It is for specific use on bayer analyzers that measure total hemoglobin and hemoglobin fractions (280, 288, and 270) and the AVOX Systems CO-Oximeters (4000 and 1000E). CC 527 may al...
Company:RNA Medical

CC 525 Blood Gas, Electrolyte, Metabolite, CO-Oximeter (Bayer®) Control

Description:...rformance of blood gas, electrolyte, metabolite, and CO-Oximeter instrumentation. The unique formulation of this control makes it the ideal choice for bayer 800 Series analyzers. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
Company:RNA Medical

QC 623 Blood Gas, Electrolyte Control

Description:...our (4) levels for monitoring analyzer performance at varying points within the clinical range. It may be used on multiple test analyzers (such as the bayer 850, Radiometer 505, and the Radiometer 600). QC623 is also for use on ITC IRMA TRUpoint analyzers (levels 1, 2, and 3 only)....
Company:RNA Medical

CC 525 Blood Gas, Electrolyte, Metabolite, CO-Oximeter (Bayer) Control

Description:...rformance of blood gas, electrolyte, metabolite, and CO-Oximeter instrumentation. The unique formulation of this control makes it the ideal choice for bayer 800 Series analyzers. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
Company:RNA Medical

Retic-Chex Linearity Control

Description:...lytic linearity of the system. Retic-Chex Linearity is available in five-vial sets with values assigned for Abbott CELL-DYN 3200, 3500, 3700 and 4000; bayer ADVIA 120; Coulter STKS, MAXM, HmX, GENS and LH 750/LH 755; Sysmex R-3000, R-3500, R-1000, RAM-1, XE-2100 and XT-2000i. Open-vial stability is five da...
Company:Streck

Para 12 Whole Blood Hematology Control, Three-part Differential

Description:... 1800; Danam Datacell18, Datacell 18MS/18MS Plus, Datacell 16CP and Excell 16; Infolab I-1800, I-1800MS/MS PLUS and I-1600; the ABX Micros 60, and the bayer Celltek M. Varying levels of lymphocytes, mononuclear cells, and granulocytes are available at the low abnormal, normal and high abnormal levels. Para...
Company:Streck

Microbumin Microalbumin Control

Description:...ch as Clinitek Microalbumin Reagent Strips and Roche Micral test strips. This control is also suitable for turbidimetric immunoassays using AU Series, bayer Clinitek 50, 100 and DCA 2000, Cobas, Diasorin SPQ Test System, Dimension, Synchron, and nephelometry using Array and Dade Behring nephelometers....
Company:Quantimetrix Corporation

GlycoHemosure Hemoglobin A1c Control

Description:... control for verification of laboratory procedures for the quantitation of hemoglobin A1c. This control is compatible with popular instruments such as bayer DCA 2000, Cobas Integra, Dimension, Hitachi, Primus CLC 330/385, and Synchron....
Company:Quantimetrix Corporation

More>>

Bayer in Medical Dictionary

Urine chemistry

...k 50) of Siemens is a laboratory equipment that we promote at Block Scientific. Using Clinitek 50 urine chemistry analyzer, you can obtain ... bayer Clinitek Atlas urine chemistry analyzer for high volume urine testing. ... Details on Clinitek Atlas Urine Chemistry Analyzer are as follows...

Bayer in Biological News

Ben-Gurion University of the Negev signs collaborative contract with Bayer CropScience

BEER-SHEVA, ISRAEL, April 8, 2009 Extreme temperatures and limited water availability are major stresses for plants and cause dramatic losses to agriculture around the world. Ben-Gurion University of the Negev has announced the establishment of a research collaboration with Bayer BioScience N.V....

VIB and Bayer join forces for plant research

Ghent, Belgium The changes in our climate, producing extreme temperatures or persistent drought, have an enormous impact on our crops − to put it briefly, the crops are experiencing stress. VIB has now concluded a research agreement with Bayer BioScience NV, the Flemish agro-biotech innovat...

CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda

...Ph.D., Global Product Vice President, Oncology, AstraZeneca Pharmaceuticals, Inc. Chetan Lathia, Ph.D., Director, Global Clinical Pharmacology, bayer Corp. Kwan Lee, Ph.D., Senior Director, Department of Biostatistics and Data Management, GlaxoSmithKline Francois Legay, Ph.D., Global H...

Entomological Society of America names 2008 award winners

...f the ESA North Central Branch's Recognition Award in Entomology. Recognition Award in Insect Physiology, Biochemistry, & Toxicology (Sponsored by bayer CropScience) This award recognizes and encourages innovative research in insect physiology, biochemistry and toxicology. The 2008 awardee, Dr. Walter...

Carbon Disclosure Project: 'World's largest corporations seek clarity on climate change regulation'

... disclosure practice are highlighted in the Carbon Disclosure Leadership Index (CDLI). The highest scoring companies in the CDLI include: BASF; bayer (Chemicals and Pharmaceuticals); Exelon; Iberdrola; Scottish & Southern (Utilities); Nissan Motor (Manufacturing); Barclays; Merrill Lynch & C...

Leading scientist named new chair of Cell Biology at Yale

...Department of Cell Biology. Additionally, Rothman will launch the Center for High-Throughput Cell Biology at Yale's West Campus, formerly the site of bayer Pharmaceuticals. Rothman will come to Yale from Columbia University's College of Physicians and Surgeons, where he is now a professor in the Depart...

MIT creates new material for fuel cells

...r goal is to replace traditional fuel-cell membranes with these cost-effective, highly tunable and better-performing materials, said Paula T. Hammond, bayer Professor of Chemical Engineering and leader of the research team. She noted that the new material also has potential for use in other electrochemical...

Entomological Society announces 2007 award winners

... International Symposium on the Biological Control of Arthropods. Recognition Award in Insect Physiology, Biochemistry, & Toxicology (Sponsored by bayer CropScience) This award recognizes and encourages innovative research in insect physiology, biochemistry and toxicology. The 2007 awardee, Dr. Michael...

20th ECNP Congress 2007, Oct. 13-17, Vienna, Austria

... for a new and better understanding of Alzheimers disease, as one of the most important future public health challenges. This work presented by Thomas bayer carries the promise of developing new treatments. Neurobiological pathways between depression and cardiovascular diseases are clarified: La...

Researchers shed light on mechanism of action used by anti-cancer drug

...were published online in the journal Molecular and Cellular Biology on June 4. According to Grant, sorafenib, or Nexavar which is manufactured by bayer Pharmaceuticals, has recently been approved for the treatment of patients with renal cell cancer, the most common form of kidney cancer in adults. It ...

Bayer in Biological Technology

DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements

WILMINGTON, Del. and MONHEIM, Germany, June 25 /PRNewswire-FirstCall/ -- DuPont (NYSE: DD ) and Bayer CropScience have entered into a series of long-term business agreements related to key plant biotechnology traits and enabling technologies that will help increase agricultural productivity arou...

Neptune Products to be commercialized by BAYER HealthCare

LAVAL, QC, June 4 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) today announced that it has signed an agreement with Bayer Healthcare, LLC for the commercialization of Neptune proprietary products in the United States. "The signing o...

Onyx Pharmaceuticals Files Complaint Against Bayer Corporation

Asserts Rights to Phase 2 Anti-Cancer Compound Discovered During Joint Research EMERYVILLE, Calif., May 17 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it has filed a complaint in the United States District Court for the Northern District of Cal...

Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services

Stemedica Cell Technologies, Inc., a leader in adult stem cell production, announced today the appointment of Michael Bayer, MD, as Director, Medical Services. Dr. Bayer will be responsible for developing pre-clinical and clinical trial protocols for use by research centers conducting pre-clinic...

Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer Schering Pharma AG

BETHESDA, Md., Jan. 12 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases today announced the signing of an option, collaboration and license agreement ...

GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years

ST. JOSEPH, Mich., Jan. 6 /PRNewswire/ -- GeneGo, Inc., a leading provider of software and high quality manually curated databases for systems biology and pathway analysis , today announced that Bayer Schering Pharma AG has renewed its MetaCore licenses for another three years. Bayer Scherin...

Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience

NEW BRUNSWICK, N.J., Aug. 1 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (Amex: SNT ) announced today that Bayer CropScience has successfully completed the first R&D milestone related to Bayer's use of Senesco's technology in Brassica oilseeds. Senesco's...

CTI Enters Into Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data for Potential U.S. Supplemental Marketing Application

Access to data may provide potential for label expansion in the U.S. SEATTLE, June 18 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC ; MTA) announced today an agreement with Bayer Schering Pharma to gain access to Bayer's phase III Zevalin(R) ([90Y]-ibritumomab tiuxet...

Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx

MEMPHIS, Tenn., Feb. 14 /PRNewswire/ -- Accelerated Community Oncology Research Network, Inc. (ACORN), today announced the initiation of a Phase 2b clinical trial evaluating the efficacy of Nexavar(R) (sorafenib) tablets in combination with the anticancer drug gemcitabine (Gemzar(R)) in patien...

Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)

VANTAS(R) to be Only Once-Yearly Implant for Prostate Cancer in U.S. Market Indevus Reaffirms Commitment to Prostate Cancer Patients LEXINGTON, Mass., Dec. 20 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) today commented on the announcement by Bayer Healthcare t...